Calyxo Closes On $50 Million Equity Financing To Support Broad Launch Of Cvac Kidney Stone Treatment

Dec 12, 2023•about 2 years ago

Amount Raised

$50 Million

PleasantonHealth CareInformation Technology

Investors

CrgQuesta CapitalAvidity Partners

Description

Calyxo, Inc., a medical device company developing next-generation treatment solutions for patients with kidney stones, has announced the closing of a $50 million Series D financing round led by Avidity Partners with significant participation from existing investors Questa Capital and CRG.

Company Information

Company

Calyxo

Location

Pleasanton, California, United States

About

Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones by delivering paradigm-shifting solutions that enable urologists to safely, effectively and efficiently achieve unrivaled clinical outcomes.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends